Treatment Overview
The CHA IUI Service in Korea represents one of the most advanced and trusted fertility programs in Asia. Operated by CHA Fertility Center, part of the globally recognized CHA Medical Group, this program combines state-of-the-art reproductive medicine, advanced laboratory science, and personalized patient care.
Intrauterine Insemination (IUI) is a minimally invasive fertility treatment that introduces high-quality, prepared sperm directly into the uterus during ovulation, significantly increasing the chance of conception. At CHA Fertility Center, IUI is enhanced through precision hormone monitoring, real-time ultrasound guidance, AI-based ovulation prediction, and the latest sperm selection technologies — making it one of the most refined IUI protocols worldwide.
Purpose & Benefits
The goal of CHA’s IUI Service is to assist couples facing mild infertility or timing-related conception challenges.
Key benefits include:
- Improved fertilization success by delivering sperm closer to the egg.
- Safe, non-surgical, and cost-effective alternative to IVF.
- Custom-tailored protocols for individual fertility profiles.
- Enhanced sperm selection using advanced laboratory techniques.
- Short treatment cycles with minimal downtime.
- Seamless transition to advanced ART (IVF or ICSI) if needed within the same network.
CHA’s multidisciplinary fertility team focuses on maximizing natural conception potential while maintaining medical safety and emotional comfort.
Ideal Candidates
The CHA IUI Program is ideal for patients with:
- Unexplained infertility after initial testing.
- Mild male-factor infertility (slightly low sperm motility or count).
- Cervical factor infertility preventing sperm passage.
- Ovulation disorders regulated by mild stimulation.
- Mild endometriosis with open fallopian tubes.
- Donor sperm use for single women or same-sex couples.
- Age under 38–40 years, with good ovarian reserve and patent fallopian tubes.
CHA’s fertility specialists conduct a detailed pre-treatment assessment to determine if IUI is the most suitable first-line therapy before proceeding to IVF or other ART procedures.
Possible Risks & Complications
IUI is generally very safe when performed by skilled specialists.
Potential risks may include:
- Mild cramping or spotting post-procedure.
- Minimal infection risk (rare under CHA’s sterile protocols).
- Ovarian hyperstimulation when using fertility medication.
- Chance of multiple pregnancies with ovulation induction.
At CHA Fertility Center, close monitoring of hormone levels and follicular development minimizes risks while ensuring optimal timing and safety.
Advanced Techniques Used at CHA Fertility Center
CHA Medical Group is globally renowned for innovation in reproductive medicine. Its IUI service incorporates the most advanced scientific methods and technologies available:
- Microfluidic Sperm Sorting: Selects sperm with superior motility and DNA integrity.
- Density Gradient Centrifugation: Concentrates healthy, motile sperm for insemination.
- MACS (Magnetic-Activated Cell Sorting): Eliminates defective or apoptotic sperm cells.
- Ultrasound-Guided Catheter Placement: Ensures precise, gentle sperm delivery into the uterine cavity.
- AI-Driven Ovulation Tracking: Accurately predicts ovulation timing for maximum conception probability.
- Endometrial Receptivity Assessment (ERA): Determines optimal implantation window in selected patients.
- Hormonal and Genetic Profiling: Used to personalize each treatment plan.
This advanced integration of technology and medical expertise defines CHA as one of the most innovative fertility institutions in Korea.
Recovery & Aftercare
Recovery from IUI is simple, and CHA provides thorough post-procedure care to ensure the best possible outcome.
Typical aftercare includes:
- Rest for 10–20 minutes post-procedure.
- Return to normal daily activities within the same day.
- Avoiding strenuous exercise for 24–48 hours.
- Luteal phase hormonal support (progesterone supplementation).
- A pregnancy test about two weeks later.
- Emotional and lifestyle support through CHA’s fertility counseling services.
Patients receive individualized aftercare plans to promote a healthy uterine environment and reduce emotional stress during the waiting period.
Results & Success Rates
CHA Fertility Center maintains exceptionally high IUI success rates compared to regional and global averages.
- Success rate per cycle for women under 35: 10–20%.
- Cumulative pregnancy rate after 3–6 cycles: 30–50%.
- Optimized outcomes through precision monitoring and individualized medication protocols.
Because CHA offers a full spectrum of fertility solutions, patients can smoothly progress from IUI to IVF or ICSI within the same advanced care ecosystem when needed.
Treatment Process at CHA Fertility Center
The CHA IUI process follows a detailed and patient-centered sequence:
1. Initial Consultation & Testing
Comprehensive fertility assessment including hormonal panels, pelvic ultrasound, semen analysis, and tubal patency evaluation.
2. Ovulation Stimulation
Customized protocols using medications like Letrozole or Clomiphene, with close ultrasound and hormone tracking.
3. Ovulation Trigger
A precise trigger injection (hCG or GnRH agonist) induces ovulation once follicles reach maturity.
4. Sperm Preparation
Laboratory sperm optimization via microfluidic sorting or gradient centrifugation.
5. Insemination Procedure
A soft, flexible catheter is used to gently place sperm into the uterus under ultrasound guidance.
6. Luteal Support & Monitoring
Progesterone or hormonal therapy supports implantation, followed by a pregnancy test at 14 days.
Why Korea and CHA Are Global Leaders in Fertility Treatment
Korea’s reproductive medicine sector, led by institutions like CHA, stands at the forefront of innovation.
Reasons for Korea’s global leadership include:
- Integration of AI-driven fertility analytics and precision medicine.
- Advanced embryology and sperm processing laboratories meeting international standards.
- High clinical success rates with minimal complications.
- English-speaking fertility specialists and international patient programs.
- Affordable treatment packages compared to Western countries.
- Seamless coordination between fertility, women’s health, and prenatal care.
CHA Fertility Center’s network of hospitals and research institutes ensures that patients benefit from ongoing scientific advancements and evidence-based care.
Cost Range for IUI at CHA Fertility Center
Costs vary based on cycle type and add-on technologies:
- Standard IUI cycle: USD 700 – 1,200.
- Advanced IUI with microfluidic sorting or genetic adjuncts: USD 1,500 – 3,000.
- Multi-cycle packages: Discounted rates for 3–6 cycle bundles.
Additional charges apply for diagnostic tests, stimulation medications, and optional reproductive health screenings.
CHA Fertility Center Locations in Korea
CHA operates multiple state-of-the-art fertility centers nationwide, including:
- CHA Fertility Center Seoul Station – Flagship facility offering comprehensive ART and IUI services.
- CHA Gangnam Medical Center – High-volume women’s hospital specializing in fertility and gynecology.
- CHA Bundang Medical Center – University-affiliated hospital with integrated reproductive research and clinical care.
Each center is equipped with cutting-edge reproductive laboratories, advanced imaging systems, and multidisciplinary fertility teams.
